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ABSTRACT
CORRELATIONAL STUDY FOR PREDICTOR VARIABLES AFFECTING LENGTH OF
STAY ON PEDIATRIC SICKLE CELL PATIENTS
By
Jenny Schott, BS, RRT
Sickle cell disease (SCD) and asthma most commonly affect African American children in the
United States. SCD is an inherited disorder and one of the most prevalent genetic diseases
worldwide. Acute chest syndrome (ACS) is a common complication associated with significant
morbidity and is the leading cause of death among patients with sickle cell disease. Asthma is
associated with an increase in SCD-related morbidity. Length of stay is a factor in determining
costs and management of healthcare resources to this pediatric patient population. PURPOSE:
The purpose of this study is to retrospectively investigate the length of stay for patients who have
asthma, acute chest syndrome, and those with both asthma and acute chest syndrome in a
pediatric population at an urban hospital. METHODS: A retrospective study using existing data
from an urban tertiary children’s hospital inpatient unit between January 1, 2012 and December
31, 2012. DATA ANALYSIS: Data analysis was performed using SPSS 17.0. Descriptive
statistics were run for each variable. Contingency tables were run to determine if a patient’s age
and diagnosis had significance on the hospital length of stay. Intercorrelations were run to
determine if age, diagnosis, and length of stay had an effect on each other. Davis conventions
were used to analyze the results. RESULTS: Descriptive statistics indicated the mean age at
discharge to be 7.02 years old, SD = +4.695 and mean length of stay 2.57 days. The data also
indicated that the mean LOS for asthma 2.32 days, SD = +1.773, mean LOS for acute chest
syndrome 3.79 days, SD = +2.239, and a mean LOS for both asthma and acute chest syndrome

ii

3.81 days, SD = +3.172. Contingency statistics showed a negligible association (reta = 0.071)
between the patient’s age and diagnosis, and a low association (reta = 0.275) between the
diagnosis and length of stay. Pearson product-moment correlation coefficients showed that the
patient’s age at discharge had a low association with length of stay (r = 0.238, p < 0.01).
CONCLUSIONS: The pediatric patient’s age and diagnosis had very little impact of their length
of stay within the hospital. The data also demonstrated that the patient population tended to be
black, younger, have asthma as a discharge diagnosis, length of stay of less than 3 days, with a
fairly even representation of males and females. Asthma represented the shortest length of stay,
followed by acute chest syndrome, and then those patients with both asthma and acute chest
syndrome, possibly suggesting that patients with co-morbidities have longer lengths of hospital
stays.
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CHAPTER I
Introduction
Sickle cell disease (SCD) is an inherited disorder and one of the most prevalent genetic
diseases worldwide, affecting over 250 million people (Poulter, Truszkowski, Thompson, &
Liem, 2011). The highest prevalence of sickle cell disease is found in Sub-Saharan Africa, South
and Central America, Saudi Arabia, and the Mediterranean (Hirani, Weibel, & Kane, 2011). In
the U.S., the incidence of the disease occurs in 1 in 500 births among African Americans and 1
in 1400 births in Hispanic Americans (Hirani et al., 2011). SCD affects approximately 7200
people in Georgia, with just over 3000 of those between 0 and 19 years old (“CDC-Sickle Cell
Disease in Georgia,” n.d.). Incidence of sickle cell complications is inversely related to age, with
the incidence of vaso-occlusive pain crisis or acute chest syndrome (ACS) decreasing steadily
from childhood to adulthood (Poulter et al., 2011). SCD related mortality rates in African
American children age 0-3 declined by 68% from 1983 to 2002 (Yanni, Grosse, Yang, & Olney,
2009). For the same time period, mortality rates for 4-9 years old decreased 39%, and ages 1014 decreased 24% (Yanni et al., 2009).
SCD is a result of a mutation in the hemoglobin gene, passed down through families, that
causes red blood cells to become sickle-shaped. These sickle-shaped cells may obstruct blood
vessels, causing pain, infection, tissue death, and injury within the major organs due to the
ineffective oxygen carrying capacity of the red blood cells (Hirani et al., 2011). There are
several different genotypes of sickle cell disease. People who inherit two sickle cell genes, one
from each parent, have what is called sickle cell anemia, or HbSS (“CDC - Facts About Sickle
Cell Disease” 2011). HbSS is usually the most severe form of all the types. HbSC is a form of
sickle cell disease in which they inherit one sickle cell gene (“S”) from one parent, and abnormal
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hemoglobin gene (“C”) from the other parent. The other common types of SCD are HbS beta 0thalassemia and HbS +-thalassemia (CDC - Facts About Sickle Cell Disease,” 2011). In each of
these types, the person has one “S” gene and one gene for beta thalassemia which is another type
of anemia. The “0” is the more severe form and “+” is the milder form of SCD (CDC - Facts
About Sickle Cell Disease,” 2011). People with one “S” gene and one normal gene carry the
sickle cell trait (HbAS). According to the Centers for Disease Control and Prevention, these
people usually do not have any signs of the disease, but they can pass their trait to their children
(CDC - Facts About Sickle Cell Disease,” 2011).
Acute chest syndrome, or ACS, is a common complication associated with significant
morbidity and is the leading cause of death among patients with sickle cell disease. ACS is also
identified as a significant risk factor for early death. ACS is characterized by a new infiltrate on
chest radiograph and some combination of fever, chest pain, and respiratory symptoms such as
tachypnea, cough, or dyspnea (Paul et al., 2011; Poulter et al., 2011). Known risk factors for
ACS development are younger age, high hemoglobin levels, lower hemoglobin F, and higher
steady state white blood cell count (Bryant, 2005). Proposed causes of ACS include infections,
pulmonary vascular occlusion, atelectasis, pulmonary edema, and bronchospasms (Taylor et al.,
2004). Although there is an increased awareness that acute chest syndrome is the leading cause
of death in patients with sickle cell disease, the diagnosis is often delayed, optimal treatment is
unknown, and the cause is usually not determined (Vichinsky et al., 2000). Access to
comprehensive, multidisciplinary care by providers familiar with the health issues of people with
SCD is lacking in much of the United States. According to the CDC, fewer than 10% of
Americans with SCD have access to specialized treatment centers for management of the disease
(“CDC - Sickle Cell Disease and Thalassemia,” 2012).
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Over the past 20 years, asthma prevalence has doubled, with about 34 million people
affected (Anim, Strunk, & DeBaun, 2011). The presence of asthma is most common in AfricanAmerican children affecting about 14.6% of the population (Anim et al., 2011). Specifically in
Georgia, asthma affects approximately 900,000 people, with African-Americans representing the
largest percentage of asthmatics with 18.6% (“CDC-Asthma in Georgia,” 2011). Low-income
populations, minorities, and children living in inner cities experience a greater number of
emergency department visits, hospitalizations, and deaths due to asthma than the general
population (“CDC - Asthma - Adolescent and School Health,” n.d.).Diagnosis of asthma is
primarily based on symptoms, family and medical history, and clinical findings, which includes
pulmonary function testing. Pulmonary function testing detects the presence of airway
obstruction and the response to treatment, typically in those patients 5 years and older.
Asthma is common chronic disorder of the airways characterized by recurrent wheezing.
Asthma is defined by reversible airway obstruction, bronchial inflammation characterized by
presence of eosinophils in the airway, and bronchial hyperresponsiveness perpetuated by irritant
stimuli (Bryant, 2005). Triggers of asthma include smoke, cold air, exercise, dust mites, pets,
and allergic rhinitis, just to name a few (Bryant, 2005). Individuals with asthma experience
episodes where airway restriction results in difficulty in breathing. The severity of asthma attacks
can range from mild to severe and can lead to hospitalization and potentially death from the most
severe cases.
Asthma is associated with an increase in SCD-related morbidity and those patients with
asthma had nearly four times as many episodes of ACS and more frequent painful episodes
(Boyd, Macklin, Strunk, & DeBaun, 2006). Children with SCD and asthma were younger at the
time of their first episode with a median age of 2.4 years versus 4.6 years without and required
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more transfusions (Boyd et al., 2006). Asthma and bronchial hyper-responsiveness are more
common in children with SCD.
Recent studies have shown that the involvement of specialists in asthma and sickle cell
care improves patient outcomes and reduces costs. Specifically, asthmatic patients cared for by
specialists have shorter lengths of stay and fewer hospitalizations (Wazeka, Valacer, Cooper,
Caplan, & DiMaio, 2001). Wazeka et al. (2001) and National Asthma Education and Prevention
Program (2007) both report that pediatric patients that have an implementation of an asthma
clinical pathway may reduce hospital length of stay and costs without increasing morbidity or
rates of readmission. Length of stay can be related to hospital policies, as well as the severity of
the illness (Kelleher, 1993).
Purpose of the Study
The purpose of this study was to retrospectively investigate the length of admission for
patients who have asthma, sickle cell disease, and those with both asthma and sickle cell disease
in the pediatric population at an urban hospital. The length of hospitalization can be important
in determining and managing healthcare resources within the hospital. It could also potentially
impact the health care costs and quality of care delivered to the patient. The desired outcome of
the study is to increase awareness of the impact of these diseases on the pediatric population and
to aid in determining which patient population is at highest risk for longer admission rates.
The following research questions were addressed to guide the acquisition of data required
to satisfy the requirements of the purpose statement.
1. What is the average patient’s age?
2. What is the patient’s gender?
3. What is the patient’s ethnicity?
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4. What is the patient’s discharging diagnosis?
5. What is the patient’s length of hospital stay?
6. Does having a comorbidity increase the hospital length of stay?
7. What pediatric age group has the shortest and longest length of stay?
Significance of study
This study is significant in that it may determine if the length of stay correlates with care
the patient receives, along with the costs incurred. This study may also determine whether using
clinical practice guidelines contributes to a shorter length of stay. It may also improve initial
physician decisions and predict patient outcomes if results can be generalized for the pediatric
population. This study may also identify certain variables that may be predictors of future failure
or success in the treatment these patients receive.
Definition of words and terms
Acute chest syndrome: A new infiltrate on chest x-ray, along with one or more of these
symptoms: fever, cough, dyspnea, or hypoxia.
Clinical practice guidelines: A range of accepted approaches for the diagnosis, management, and
treatment of a specific disease utilized by medical personnel.
Length of stay: The duration of stay at the same hospital from admittance to discharge.
Hyperresponsiveness: Exaggerated narrowing of the airways as a result of being exposed to
stimuli.
Painful crisis: Uncontrolled pain that causes severe distress for the sickle cell patient.
Pediatric population: Includes those 0 to 18 years old
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Delimitations
This study includes a pediatric population between January 1, 2012 and December 31,
2012. The results of this study can only be generalized to this population group.
Although these limiting factors are considered outside the control of the researcher, it is
important to recognize each one in order to effectively evaluate the significance of this study.
These limitations are not only present in the research setting, but are also limiting factors in the
clinical setting.
Assumptions
The intention of this study is to prove that patients with both asthma and sickle cell
disease have a longer length of stay in the hospital. The reason for this assumption is that
comorbidities often cause more complications and longer lengths of stay. Complications can
arise from determining how to treat the patient without negatively impacting the other disease
processes. In patients with SCD who have developed ACS, it will be assumed that the length of
stay will be longer compared to those patients without ACS. ACS is a more serious
complication, with significant increases in early death.
It is also assumed that those patients who were treated according to a clinical practice
guideline will have a shorter length of stay, as these guidelines have been proven to efficiently
treat patients with that specific disease. Additionally, it is assumed that patients older than 5
years will have a diagnosis of asthma, or asthma with sickle cell disease due to the complications
with diagnosing asthma in those patients younger than 5 years.
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CHAPTER II
Review of Literature
Health care spending in the United States has been growing substantially compared with
other developing nations, with an expenditure of over $2.5 trillion in 2009 (Oyetunji et al.,
2013). Yet, there seems to be no slow down because health care expenditures have been on the
rise for the last 10 consecutive years (Oyetunji et al., 2013). Rising costs have attracted the
attention of the healthcare community as an important public health issue (Green et al., 2012). As
a consequence, focus has shifted to making health care delivery more efficient without
sacrificing quality of care (Oyetunji et al., 2013). Although many measures of quality care are
being evaluated and validated, one measure that has been advocated as a metric for both quality
of care and the efficient use of health care dollars is hospital length of stay (Oyetunji et al.,
2013). Given the current era of maximizing every health care dollar without necessarily
sacrificing quality, it is important to assess the quality of health care provided to ensure patients
are receiving adequate care (Oyetunji et al., 2013). Therefore, length of stay (LOS) is a
potentially important outcome measure and needs to be investigated to evaluate its efficacy in
correctly predicting patient outcome (Oyetunji et al., 2013).
SCD leads to a considerable burden on the medial system, due to the acute and chronic
complications and emergency department utilization of these patients. Twenty years ago, infants
born with SCD often did not survive childhood. Improvements in medical technology and drug
therapy have contributed to patients with SCD surviving well into adulthood (Green et al., 2012).
Despite that, health and life-expectancy outcomes are dependent on disease management and
continuity of care throughout childhood, adolescence and adulthood (Green et al., 2012).
Characterized by painful vaso-occlusive episodes, increased susceptibility to infection, and
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serious complications such as acute chest syndrome and stroke, SCD leads to frequent
emergency room visits, hospitalizations, and consequently, high health care expenditures
(Mayer, Konrad, & Dvorak, 2003). Chronic diseases like SCD can be devastating physically,
financially, and socially (Mayer et al., 2003). Admittedly, determining with high accuracy is
difficult as estimates are compounded by multiple variables such as patient care, insurance, and
morbidity, all of which can influence length of stay (Mak, Grant, McKenzie, & McCabe, 2012).
Children with SCD like most children with complex, chronic health conditions, receive
substantially more medical care than children without SCD (Bundy, Strouse, Casella, & Miller,
2011).
Multiple variables can influence length of stay. Differences in socioeconomic status can
have an impact on care. These factors include age, insurance status, and living in an urban area.
Peak incidence for acute chest syndrome in children is between 2-4 years old and gradually
declines with age (Paul, Castro, Aggarwal, & Oneal, 2011). ACS in the first 3 years of life
significantly increased the odds of more frequent episodes during childhood (Paul et al., 2011).
However, patients 21 and older were predictive of higher emergency department (ED) visit rates
and were more likely to visit multiple facilities (Wolfson, Schrager, Khanna, Coates, & Kipke,
2012). In one study, approximately 73% of ED visits by SCD patients were in adults 20 and
older (Yusuf, Atrash, Grasse, Parker, & Grant, 2010).
According to Mvundura, Amendah, Kavanagh, Sprinz, and Grosse, (2009) children
enrolled in Medicaid programs had significantly more ED visits and were significantly more
likely to have an inpatient admission compared with privately insured patients. Children with
SCD with Medicaid had about 4 times more ED visits than those with other insurance, and 40%
fewer outpatient visits (Myundura et al., 2009). The prevalence among African Americans and
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Hispanics of lacking insurance, being underinsured, or on Medicaid could be a contributing
factor (Yusuf et al., 2010). Wolfson et al. (2012) correlates private insurance, as well as being
uninsured with the association of lower rates of ED visits. Urban access to care has been shown
to effect patients with SCD. Patients further from a self-identified provider of comprehensive
SCD care had higher rates of ED visits with a lower likelihood of inpatient admission (Wolfson
et al., 2012). Distance from a comprehensive SCD center likely represents a barrier to care.
(Wolfson et al., 2012). There were just fewer than 3,000 patients included in the Wolfson et al.
(2012) study and 5% of the sample was responsible for 40% of the visits. While we do not know
the characteristics of the 5%, it may not be representative of the population being studies.
Inconsistencies in self-identification and single defined categories in race and ethnicity
accuracies are limitations.
As of 2008, asthma was estimated to affect 7 million children in the United States and
just over 297,000 children in Georgia (“CDC-Asthma in Georgia,” 2011). It is the most common
chronic disease of childhood and accounts for about 190,000 pediatric hospitalizations yearly in
the United States (Edwards & Fox, 2008). No other single disease accounts for a larger
proportion of health care costs than asthma, with costs of more than 12.7 billion dollars per year
(Shelledy, McCormick, LeGrand, Cardenas, & Peters, 2005). Asthmatic patients cared for by
specialists have shorter lengths of stay and fewer hospitalizations (Wazeka et al., 2001). The
data show that the average overall LOS for all patients decreased from 4.25 days in 1994 to 2.7
days in 1998 (Wazeka et al., 2001). Total hospital charges for all pediatric asthma admissions
decreased by 26% from 1995 to 1998, from a mean of $9,329.52 per asthma admission in 1995,
to a mean of $6,875.90 per admission in 1998 (Wazeka et al., 2001). Overall pediatric nursing
costs decreased by 35% from 1995 to 1998; general nursing costs decreased by 27% per patient
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case from 1996 to 1998 (Wazeka et al., 2001). Total medication acquisition costs were reduced
by 40% from 1996 to 1998 (Wazeka et al., 2001). Shelledy et al. (2005) also found a decrease in
overall costs. Hospital costs decreased from $7,867 to $806 when in-home asthma assessment
and teaching program was provided by respiratory therapists (Shelledy et al., 2005). However,
the cost of implementing the program was approximately $640 per patient (Shelledy et al.,
2005).
Given growing demands to manage costs and maximize efficiency in acute hospital
services, information on patterns of resource utilization, including length of hospital stay, is
valuable (Moloney, Smith, Bennett, O’riordan, & Silke, 2005). Accurate predictions of patient
length of stay (LOS) in the hospital can effectively manage hospital resources and increase
efficiency of patient care (Mak et al., 2012). The literature review will offer a subjective
comparison and impact of the length of hospitalization for children with asthma, sickle cell
disease, and those with both asthma and sickle cell disease. It will focus on outcomes such as
length of stay, impact of utilizing clinical pathways, and readmission rates. Resources for the
review were derived from CINHAL and PubMed using the following search terms: “asthma”,
“acute chest syndrome”, “hospitalization”, “risk factors”, and “sickle cell” within the pediatric
population.
Impact of Length of Stay
Patients with SCD make relatively high use of urgent care services, including inpatient
care (Green et al., 2012). According to Green et al. (2012), 36% of SCD patient admissions
resulted in a length of stay of less than two days, and 74% of total bed days are patients with
multiple admissions (Green et al., 2012). Patients with short length of stay and multiple
admissions may be good candidates for primary care interventions to reduce their risk of SCD-
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related complications and admissions (Green et al., 2012). They may also benefit from more
supportive management when they attend emergency departments, sickle cell centers and
outpatient clinics, as many aspects of the management of SCD patients are outside the scope of
primary care teams (Green et al., 2012). Improper ED attendance diverts ED staff attention and
resources from severe and acute cases that need urgent hospital care. In addition, it adds to the
waiting times in the ED, compromises the quality of care a patient receives and increases cost
(Green et al., 2012). This analysis of sickle cell crisis admissions provided an opportunity to not
only characterize the admissions but to identify practices with higher levels of admissions
especially related to multiple admissions or short length of stays (Green et al., 2012). It also
establishes a baseline to monitor progress and validate associations in relation to improving
primary care support for patients and reducing ED admissions (Green et al., 2012).
As anticipated, the number of major comorbidities is associated with higher expected
average daily charges and total charges and longer lengths of stay (Mayer et al., 2003). Expected
total charges for an individual without major comorbidities total $4,029 (Mayer et al., 2003). For
each additional comorbidity, charges increase by $1,000 or more (Mayer et al., 2003). With each
additional major comorbidity, an increase of approximately $100 in average daily charges and an
increase of three-quarters of a day in expected length of stay (Mayer et al., 2003). This suggests
that the significance of the expected increase in resource utilization associated with each
additional comorbidity increases as the total number of comorbidities increases (Mayer et al.,
2003). The results of Mayer et al. (2003) study strongly suggest that disease severity plays the
primary role in determining the level of hospital resource utilization among this sample of
hospitalizations (Mayer et al., 2003). Hospitalizations complicated by comorbidities have
substantially higher lengths of stay and total charges (Mayer et al., 2003). In addition, patients
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admitted through emergency departments may lack a routine source of ambulatory care or be
characterized by chronic mismanagement of their disease (Mayer et al., 2003). One study found
lower rates of emergency department and inpatient visits among sickle cell patients using
comprehensive ambulatory clinics, suggesting that aggressive outpatient management may avoid
more serious illness and minimize the need for intensive treatment in an inpatient setting (Mayer
et al., 2003).
Length of Stay
Poulter et al. (2011) found that age, time to ACS diagnosis, use of medications, and days
of oxygen supplementation accounted for 49% of the variability in length of hospitalizations.
Time to ACS diagnosis and days of oxygen supplementation were independent predictors of
length of hospitalization. This study demonstrated that ACS is less severe in the pediatric patient
with hemoglobin SC disease compared to hemoglobin SS disease. Vichinsky et al. (2000) found
no difference in hospitalization length for ACS by genotype. These findings were consistent
with other research. Vichinsky et al. (2000) and Taylor et al. (2004) determined that the average
length of hospitalization was approximately 10 days for patients with ACS. Prolonged
hospitalization was found in older patients, patients with pain in arms and legs at presentation,
those with low platelet count at diagnosis, and those with extensive radiographic abnormalities,
transfusion, and respiratory failure (Vinchinsky et al., 2000). Panepinto, Brousseau, Hillery, and
Scott (2005) also found that the LOS was longer for children who were older; however, they
found the average LOS was 4.4 days and increased by nearly 2 days for those children 15-18
years of age. Panepinto et al. (2005) found a strikingly large number of hospitalizations and
significantly longer LOS for VOC in older children with sickle cell disease compared to younger
children (Panepinto et al., 2005). In Panepinto et al. (2005), age appears to be a marker of disease
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severity; however, the etiology of this is unclear. Conversely, the study by Paul et al. (2011)
showed children who developed ACS had longer hospital stays and more frequently required
admission to the intensive care unit.
Visits for SCD were the most likely to result in admission (45%) compared with asthma
(12%) (Bundy et al., 2011). Three quarters of visits with primary diagnoses of SCD occurred
among children who were seen in the same institution’s emergency department on more than 1
occasion during 2003 to 2004, compared with 51% of asthma visits (Bundy et al., 2011). Among
these repeat ED users, visits for SCD remained more likely than those for asthma to be
considered urgent or result in admission (Bundy et al., 2011). Visits for children seen greater
than 2 times for SCD in the same institution had 24 times the odds of those for children seen
greater than 2 times for asthma of being deemed urgent by the resource utilization method or
result in admission (Bundy et al., 2011). Bundy et al. (2011) observed that children with SCD
with multiple visits to the same ED during the study period were substantially more likely than
asthmatic children with multiple visits to be hospitalized or have urgent visits (Bundy et al.,
2011).
The hospitalization rate remains substantial, generating nearly one-half of all US health
care costs for asthma (Eisner, Katz, Yelin, Shiboski, & Blanc, 2001). Hospitalization rates for
asthma have actually increased in some demographic subgroups, such as young adults and the
urban poor, despite recent therapeutic advances (Eisner et al., 2001). Understanding the factors
underlying hospitalization for asthma could help explain the recent rise in asthma morbidity
(Eisner et al., 2001). Previous studies have identified several factors that contribute to increased
hospitalization risk among adults with asthma (Eisner et al., 2001). Demographic characteristics,
such as poverty, low educational attainment, female gender, and African–American race, have
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been associated with a greater risk of hospitalization for asthma (Eisner et al., 2001). Poor health
care access and inadequate preventive asthma care have also been frequently cited as
contributing factors (Eisner et al., 2001). In these studies, however, separating the independent
effects of demographic characteristics, health care access, and disease severity has been difficult
(Eisner et al., 2001).
Clinical Practice Guidelines Affecting Length of Stay
Clinical practice guidelines (CPGs) are evidence-based multidisciplinary care plans
which describe the essential steps needed in the care of patients with a specific clinical problem
(Rotter, Kinsman, James, Machotta, & Steyerberg, 2012). They are used to translate clinical
guidelines into local protocols and clinical practice (Rotter et al., 2012). Clinical practice
guidelines have been proposed as a strategy to optimize resource allocation in a climate of
increasing healthcare costs (Rotter et al., 2012). They are usually developed for inpatient
diagnoses requiring multi-disciplinary inputs and for which care is relatively predictable
(Banasiak & Meadows-Oliver, 2004). The goals of clinical pathways are to reduce unintended
variations in care, reduce resource utilization, improve patient education, and improve quality of
care (Banasiak & Meadows-Oliver, 2004).
Management of SCD and ACS is primarily supportive care and includes respiratory
therapy, antibiotics, and red-cell transfusions (Crabtree et al., 2011). An important aspect of ACS
management is early diagnosis (Taylor et al., 2004). However, symptoms can vary widely
between patients; therefore clinical examination is potentially the most misleading aspect of
assessment of ACS (Taylor et al., 2004). Crabtree et al. (2011) examined the implementation of
an evidence-based guideline for children and adolescents with SCD with ACS or at risk for ACS
(Crabtree et al., 2011). The guideline was based on interventions to potentially decrease the
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development of ACS in those at risk, heightened alert for ACS detection, and aggressive
treatment to prevent significant morbidity and mortality (Crabtree et al., 2011). A pilot data was
collected before Crabtree et al. (2011) implemented their CPG, and found that the average length
of stay had not been affected and pulmonary interventions and clinical respiratory score (CRS)
assessments were not being administered according to the guideline (Crabtree et al., 2011).
Outcome measures designed to evaluate success of the guideline included length of stay, number
of exchange transfusions, average cost per SCD admission, and adherence to respiratory
interventions (Crabtree et al., 2011). These outcomes indirectly measured morbidity and the
efficiency of care. Implementation of this guideline demonstrated that even when evidence is
limited, standardization of care can produce significant improvement in clinical outcomes
(Crabtree et al., 2011).
Average length of stay was reduced from 5.8 days during the pilot study and before
implementation to 4.1 days after the institution of the CPG (Crabtree et al., 2011). Average cost
per SCD admission decreased from $30,359 in fiscal year 2008 before implementation of the
guideline to $22,368 in the first 6 months of 2010, which is a reduction of $7,991, or about 26
percent decrease in cost (Crabtree et al., 2011). Crabtree et al. (2011) attributed the decrease in
average length of stay and room charges for SCD admissions after implementation of the
guideline (Crabtree et al., 2011). Average length of stay for patients with SCD decreased from
5.4 days in 2007, 2008, and 2009 to 4.1 days in the first 6 months of fiscal year 2010 (Crabtree et
al., 2011). The mainstay of successful treatment for children with SCD with ACS or at risk for
ACS is high-quality supportive care (Crabtree et al., 2011). Implementation of a standardized
approach to care for children at risk for ACS and those with ACS revealed significant changes in
clinical outcomes (Crabtree et al., 2011). The use of the CRS as a standardized method for
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evaluating clinical respiratory status played an important role in minimizing variation in
assessment as well as management for these children (Crabtree et al., 2011).
As with SCD, some institutions have developed and implemented clinical pathways due
to the increasing number of children with asthma being hospitalized (Banasiak & MeadowsOliver, 2004). Since 1980, the prevalence of people ever having been diagnosed with asthma
increased nearly 74% (Banasiak & Meadows-Oliver, 2004). Banasiak and Meadows-Oliver
(2004) found that children cared for using an inpatient asthma clinical guideline had a
remarkably shorter hospital stay than did children who were not cared for using an asthma
pathway (Banasiak & Meadows-Oliver, 2004). Similarly, Johnson, Blaisdell, Walker, and
Eggleston (2000) showed that when using a clinical guideline in the treatment of children with
asthma, the length of stay was reduced for those children (Banasiak & Meadows-Oliver, 2004).
On the other hand, Wazeka et al. (2001) did not find a significant difference in the length of stay
for children using an asthma clinical pathway versus those who did not within the first year of
using the clinical pathway at their institution. However, this group did find that the length of stay
decreased significantly the longer that the pathway was used (Wazeka et al., 2001).
Like Banasiak and Meadows-Oliver (2004) and Johnson et al. (2000), Edwards and Fox
(2008), found that the use of an inpatient asthma clinical practice guideline decreases length of
stay. Length of stay for clinical pathway patients was 2.33 ± 1.06 days with an average stay of
2.33 days (Edwards & Fox, 2008). Length of stay for control patients was 2.7 ± 1.06 days with
an average stay of 2.70 days (Edwards & Fox, 2008). Use of the asthma clinical pathway
reduced length of hospital stay by 0.372 days (Edwards & Fox, 2008). Unfortunately this study
failed to show improved quality of care, such as increased receipt of asthma education,
appropriate prescribing of discharge medications based on asthma classification, or a reduced
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readmission rate (Edwards & Fox, 2008). Likewise, Shelledy et al. (2005) found that the mean
LOS decreased from 3.10 days to 0.63 days in moderate to severe asthmatics who were given a
an in-home asthma teaching program. Conversely, Kwan-Gett et al. (1997) in a retrospective
study of a pediatric inpatient asthma clinical guideline, found no significant difference in LOS
following implementation of a clinical practice guideline. However, the average LOS prior to
pathway implementation was only 2 days (Kwan-Gett et al., 1997). Johnson et al. (2000) in a
prospective, randomized, controlled trial showed a decreased length of stay of 13 hr (from 2.23
days to 1.68 days) and decreased routine charges in pediatric patients treated along asthma
clinical guidelines in an intervention compared to a control group.
Conclusion
Sickle cell disease and acute chest syndrome affect the lives of many children within the
African American and Hispanic communities. The disease is a condition that is difficult to cope
with, especially for children. It is a chronic condition that will ultimately take their life, much
too early. Despite recent advances in our knowledge of ACS and SCD, mortality still remains a
large factor for these patients. Understanding the variables and risks factors for this disease can
help providers with delivering the best care possible to extend the lives of many.
As with sickle cell disease, asthma is a chronic disease that affects many American
children. The rising costs of healthcare are becoming a concern and burden for many people.
Focus is on how to deliver more efficient care, without sacrificing quality of care. One
parameter that has been advocated as a systematic measurement for both quality of care and the
efficient use of health care dollars is the inpatient length of stay. In addition, length of stay is
important to compare between those children with asthma and sickle cell disease, and those with
only asthma or sickle cell disease. Understanding the effects of comorbidities on children may
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help to provide a more focused approach to care, with an impact of length of stay and potentially,
costs.
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CHAPTER III
Methodology
The study performed is a retrospective study using existing data from an urban tertiary
children’s hospital. The data will be used to answer the preset research questions.
1. What is the average patient’s age?
2. What is the patient’s gender?
3. What is the patient’s ethnicity?
4. What is the patient’s discharging diagnosis?
5. What is the patient’s length of hospital stay?
6. Does having a comorbidity increase the hospital length of stay?
7. What pediatric age group has the shortest and longest length of stay?
Population
The subjects used were children from an urban tertiary children’s hospital inpatient unit
between January 1, 2012 and December 31, 2012. The patients for this study will be a cross
section of different ages and genders that will be utilized to compute statistics and answer preset
research question. The inclusion criterions were as follows: children who were admitted with
the diagnosis of either asthma, acute chest syndrome, or a combination of asthma exacerbation
and acute chest syndrome. Children that were excluded were those that had any other
discharging diagnosis than asthma, acute chest syndrome, or a combination of asthma and acute
chest syndrome and those patients that were transported to another hospital.
Instrumentation
All data collection was performed by a Clinical Business Requirements Analyst at the
approved hospital for this project in accordance with the rules and regulations of the approved
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hospital. The data was collected from computer charts at the urban tertiary children’s hospital
inpatient unit under the direction of the researcher. Data was collected as part of documentation
files in the computerized charting database utilized by the hospital and all identifiable markers
were removed. Approval was granted by the Institutional Review Board at Georgia State
University and from the hospital where data collection was completed.
All possible variables were discussed and critiqued for this study. Variables used
included age, race, gender, hospital inpatient length of stay, and discharging diagnosis. The
researcher requested the above variables be gathered for the previous year, leaving out all direct
patient identifiers. The discharge diagnoses were based on ICD-9 codes, which is a classification
system used to assign codes for patient diagnosis within a hospital. Patients included in the
study had ICD-9 codes of 517.3 (acute chest syndrome), 493 (asthma), or a combination of both
at the time of discharge. The ICD-9 code for asthma includes all types of asthma exacerbations.
All ages, races, and genders were included in the study. The Clinical Business Analyst in the
Business Intelligence department at the study hospital searched for the data with the above
parameters, as outlined by the IRB requirements. After the researcher met with the analyst, the
analyst ran a formula to gather the data in the computerized charting database to extract the
information for 25% of the data, make sure it would be reliable, and answer what we wanted.
Upon reviewing the preliminary data, 12 months of data were ran. A report was generated from
Epic patient charting software and identifiable markers were excluded for the researcher, and a
copy was kept at the urban tertiary children’s hospital inpatient unit.
Once the data reports were created, it was checked for variability by a major professor in
the Respiratory Care Program. To ensure reliability of measure, the instrument was used on a
selected group of patients. This patient group was checked again by the analyst at the urban
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tertiary children’s hospital inpatient unit to make sure that what was recorded on each instrument
matched that in the patient files. The patients were selected by chart review from January 1,
2012, to December 31, 2012. All of the patients selected were first time admittance for the year.
If a patient was admitted multiple times during the year, only their first admittance was included.
Inclusion criterion was specifically discharge diagnosis that included either asthma, acute chest
syndrome, or a combination of acute chest syndrome and asthma. Exclusion criterion included
those that had another diagnosis than asthma or sickle cell disease, and those patients that were
transported to another hospital. The patient’s variables were recorded and placed into the
instrument for further evaluation and analysis.
Data Analysis
All statistical analyses were run using SPSS 17.0 statistical software. Descriptive
statistics were calculated for each variable. Nominal data was used for gender, race, and
discharging diagnosis. For example, male patients were assigned 1, female patients were 2.
Black patients were given number 1, Hispanic patients were 2, other was given 3, and white
patients were given 4. Patients with discharge diagnosis of acute chest syndrome were assigned
1, asthma patients 2, and those with both acute chest syndrome and asthma were given 3. Age
and length of stay were run as ratio data. The magnitude of correlations between variables was
interpreted using the Davis conventions (Davis, 1971).
Coefficient
.70 or higher
.50 to .69
.30 to .49
.10 to .29

Description
Very strong association
Substantial association
Moderate association
Low association

.01 to .09

Negligible association
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Person Product Moment correlation coefficients were calculated for all ratio data. Eta
correlation coefficients were used for calculations made between ratio and nominal data. The
data was placed into the tables by a brief narrative.
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CHAPTER IV
Results
The purpose of this study was to retrospectively investigate the length of admission for
patients who have asthma, acute chest syndrome, and those with both asthma and acute chest
syndrome in the pediatric population at an urban hospital between January 1, 2012, and
December 31, 2012. This research study explored correlations between each variable to increase
awareness of these parameters and to aid in determining which patient population is at highest
risk for longer admission rates.
Descriptive Data
Sex, race, discharge diagnosis, age, and length of stay are presented in multiple tables
below. Four hundred forty nine pediatric charts were included in this study. The mean age of
these pediatric patients was 7.02 years old at the time of discharge, with a standard deviation of
4.695. The frequency of pediatric males and females included in the study are represented below
in Table 1. Males represent just over half of the sample population with 245, while the number of
females included in the study was 204.

Table 1. Sex (n=449)
Frequency

Percent

Male

245

54.6

Female

204

45.4
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The races of those patients included in the study are shown in Table 2. The Black race
was represented 92% of the study, or 413 pediatric patients. Fourteen hispanic children were
included in the study, while there were 18 pediatric patients that were represented in the other
race category. The least represented race was white, with 4 patients, or 0.9% of this study
population.
Table 2. Race (n=449)
Frequency

Percent

Black

413

92.0

Hispanic

14

3.1

18

4.0

4

0.9

Other
White

The discharge diagnosis of the pediatric population included in this study were
represented as Acute Chest Syndrome, Asthma, or both ACS and Asthma as shown in Table 3.
Acute Chest Syndrome accounted for 11.8%, or 53 pediatric patients. Asthma diagnosis
represented the majority of the patients, with 375 or 83.5%. Those patients with both ACS and
Asthma were 21 pediatric patients, or 4.7%.
Table 3. Discharge Diagnosis (n=449)

Acute Chest
Syndrome
Asthma
Both (ACS and
Asthma)

Frequency

Percent

53

11.8

375

83.5

21

4.7
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The mean length of stay per diagnosis is represented in Table 4. Asthma accounted for
the shortest length of stay, with a mean of 2.32 days and a standard deviation of 1.773. Acute
chest syndrome had a mean of 3.79 days, with a standard deviation of 2.239. Patients with both
asthma and acute chest syndrome accounted for the longest average length of stay, with a mean
of 3.81 days and a standard deviation of 3.172.
Table 4. Length of Stay per diagnosis (n=449)

Acute Chest
Syndrome
Asthma
Both (ACS and
Asthma)

Mean

Std. Deviation

3.79

2.239

2.32

1.773

3.81

3.172

Figure 1 represents the length of stay of the patients included in the study. The majority
of patients, or 81.3 percent, stayed in the hospital for 3 days or less. The length of stay with the
most patients was 2 days, which accounted for 161 patients, or 35.9 percent of the total
population.
LOS (days)
180
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Figure 1. Length of Stay (days)
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Figure 2 shows the dispersion of the age of the patients included in this study. The most
represented patients in the study were ages 4, 5, 6, and 1, respectively. The least represented
patients were ages 18, 15, and 16, respectively. Four years old represented the highest number of
patients in the study, with 50. Eighteen years old represented the fewest number of patients in
the study, with 4.
Age
60
50
40
30
20
10
0
0

2

4

6

8 10 12 14 16 18

Figure 2. Age in years of admitted patients
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Correlations
Intercorrelations are presented in Table 5. According to the Davis conventions, the
patient’s age at discharge had a low association with length of stay (r = 0.238, p = 0.000).
Therefore, the patient’s age has very little impact on their length of stay in the hospital.
Table 5. Intercorrelations (n = 449)

Age (at the time of
discharge)
Length of Stay (LOS)

Pearson
Correlation
Sig. (2-tailed)
Pearson
Correlation
Sig. (2-tailed)

Age

LOS

1

.238**
.000

.238**

1

.000

Note: All coefficients were Pearson product-moment correlations.
**. Correlation was significant at the 0.01 level (2-tailed).

According to the Davis conventions, there was a negligible association (reta = 0.071)
between the patient’s age and diagnosis. As indicated, the patient’s age does not affect which
diagnosis the patient will have.
According to the Davis conventions, there was a low association (reta = 0.275) between
the length of stay and diagnosis. As indicated, the patient’s diagnosis has little impact of the
patient’s length of stay. However, length of stay has more of an impact on diagnosis than age.
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CHAPTER V
Discussion
Acute chest syndrome is a common complication associated with significant morbidity
and is the leading cause of death among patients with sickle cell disease. ACS is also identified
as a significant risk factor for early death. Asthma affects millions of children and is associated
with an increase in SCD-related morbidity. Recent studies have shown that the involvement of
specialists in asthma and sickle cell care improves patient outcomes and reduces costs.
Therefore it is crucial to find and compare length of hospital stay and whether co-morbidities
complicate pediatric hospital stays. Length of stay is a measure in determining overall costs and
whether a specific patient population is most at risk for longer hospital stays.
The focus of this study was to investigate the length of hospital stay for pediatric patients
who have asthma, acute chest syndrome, and those with both asthma and sickle cell disease at a
local urban hospital. The mean length of stay was 2.32 days in the asthma pediatric population.
Acute chest syndrome followed, with a mean length of stay of 3.79 days. The longest mean
length of stay was for patients with both asthma and acute chest syndrome at 3.81 days. The
mean length of stay for patients with both asthma and acute chest syndrome is relatively similar
to those patients with acute chest syndrome alone. Acute chest syndrome may have more of a
significant role in the length of stay versus asthma, as evidenced by a length of stay that was 1.5
days shorter. However, when measuring the association between length of stay and diagnosis,
there was a low association. This could be due to the fact that 83.5% of the study population was
made up of pediatric patients diagnosed with asthma. Acute chest syndrome accounted for
11.8% of the study, while those with both asthma and acute chest syndrome only represented
4.7%. In the general pediatric population, the incidence of acute chest syndrome is considerably
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less than the incidence of asthma. Our study included 53 pediatric acute chest syndrome patients
and 21 patients with both ACS and asthma. Poulter et al. (2011) examined 71 pediatric patients
with both ACS and asthma. Bryant et al. (2005) included 60 acute chest syndrome patients in
their study, and Taylor et al. (2004) included 45 acute chest syndrome patients.
Our study showed similar results in length of stay for pediatric asthma patients. Shelledy
et al. (2005) found that mean hospital length of stay for pediatric asthma patients was 3.10 days
(Shelledy et al., 2005). Another study showed average overall length of stay for asthma patients
decreased from 4.25 days in 1994 to 2.7 days in 1998 (Wazeka et al., 2001). The decrease in
length of stay by 1.5 days over a four-year period from 1994 to 1998 could even be lower today
and similar to the length of stay that our study found.
While our study found that length of stay for sickle cell patients was close to 4 days,
Green et al. (2012), found that 36% of SCD patient admissions resulted in LOS of less than two
days. However, the study does was not specific to the reason for admission or types of
complications of these patients. Our study only looked at sickle cell patients with acute chest
syndrome, which is the most complex and life-threatening complication of sickle cell disease.
Similar to our study, Crabtree et al. (2011) found the average length of stay for patients with
SCD decreased from 5.4 days in 2007, 2008, and 2009 to 4.1 days in early 2010 due to
implementation of educational interventions. The study in 2010 just included the first 6 months;
therefore it may not include the same amount of data from the previous three years studied.
Vinchinsky et al. (2000) found that the average length of hospitalization for acute chest
syndrome pediatric patients was 10.5 days and that prolonged hospitalization was found in older
patients. Vinchinsky et al. (2000) included 30 centers and 538 patients, some of which were on
mechanical ventilation. Paul et al. (2011) also showed children who developed ACS had longer
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hospital stays and more frequently required admission to the intensive care unit. Our study did
not include those patients admitted to the intensive care unit, which could impact the overall
length of stay. In addition, our study only included unique patient visits. Repeat admissions were
excluded. There is the possibility that degree of disease severity could impact the overall length
of stay. Taylor et al. (2004) also found the average length of stay was 10 days for patients with
sickle cell disease, with 60% of patients staying more than 8 days. However, Taylor et al. (2004)
included patients up to thirty-seven years old whereas our oldest patients were eighteen. Another
study found the mean length of hospital stay to be 6.4 days in patients with both ACS and
asthma, while those with ACS had a mean LOS of 8.6 days (Bryant 2005). Bryant (2005)
research suggests that co-morbidities do not impact the length of stay. In contrast, Mayer et al.
(2003) found that hospitalizations complicated by co-morbidities have substantially higher
lengths of stay and total charges.
Statistics in the United States show that SCD is most common among African Americans,
with the incidence of SCD occurring in 1 in 500 births, followed by Hispanic Americans
occurring in 1 in 1400 births (Hirani et al., 2011). In addition, asthma is most common in
African American children (Anim et al., 2011). Our study was consistent with the overall sickle
cell disease and asthma population with 92% of our study being African American, 3.1%
Hispanic, 0.9% White, and 4% as other race not represented from one of those above.
Both Paul et al. (2011) and Bryant (2005) found that peak incidence for acute chest
syndrome in children is between 2-4 years old and gradually declines with age. The mean age of
our study was 7.02 years old and showed that the length of stay decreased with age after 3 years
old. However, our study did not show the differences in length of stay with diagnosis per age
group. Panepinto et al. (2005) also found that the LOS was longer for children who were older;
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however, they found the average LOS was 4.4 days and increased by nearly 2 days for those
children 15-18 years of age. Our study did not show a correlation between age and length of
stay. Conversely, Panepinto et al. (2005) found a strikingly large number of hospitalizations and
significantly longer LOS for VOC in older children with sickle cell disease compared to younger
children (Panepinto et al., 2005). In Panepinto et al. (2005), age appears to be a marker of
disease severity; however, the etiology of this is unclear. Taylor et al. (2004) found that the age
group of 13 to18 years old presented with the greatest number of symptoms consistently, while
our study for the same age group was the least represented group, with only 16.2% of our study.
Bryant (2005) found that development of ACS is favored by a younger age, high hemoglobin
levels, lower hemoglobin F, and higher steady state white blood cell count. The study ranged
from 1.5 year old to17 years old and represented 55% female and 45% male (Bryant 2005). Sixty
children with SCD were included in the study and 53% had asthma prior to development of ACS
(Bryant 2005). The study didn’t show any differences between male and female (Bryant 2005).
No significant differences between age, sex, hemoglobin level, or LOS of children with asthma
and SCD and those without (Bryant 2005). As with our study, age and diagnosis were not
significant factors in the length of stay in patients with asthma, acute chest syndrome and those
with both asthma and acute chest syndrome. However, Taylor et al. (2004) found a difference in
length of stay for males and females. Length of stay for males was 11.4 days versus 9.7 days for
females (Taylor et al., 2004). This study included patients ranged from 1 year old to 37 years
old, with 46 percent of cases under 13 years old (Taylor et al., 2004). Older patients may have
impacted the length of stay between males and females.
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Recommendations for future research
Future research in the area of length of hospital stay and disease management in the
pediatric population should be continued. With increasing health care costs, length of stay is
one measure that affects those costs. Finding ways to decrease the length of hospital stay for
pediatric patients without sacrificing quality of care can greatly impact the future of health care
and the health of the patient.
While there is an abundance of research on asthma, more research could be focused on
sickle cell disease, specifically acute chest syndrome, as it is the leading cause of death in those
patients. There are national clinical practice guidelines in caring for the pediatric asthma
patients, which have shown to decrease frequency and length of hospitalization when followed.
The etiologies of asthma are well understood, as is the treatment plan. Therefore, mortality has
significantly decreased over the last 20 years. On the other hand, acute chest syndrome is not
well understood, and how asthma may play a role in the development of acute chest syndrome.
Even though sickle cell disease only impacts a relatively small number of Americans compared
with asthma, creation of clinical practice guidelines could impact the care and length of stay for
those patients.
Future studies could include a larger population of patients with acute chest syndrome
and those with both asthma and acute chest syndrome to determine if asthma does have a role in
longer hospital stays or more complications. In addition, those patients admitted to the intensive
care unit could be included to determine if disease severity plays a role in the care they receive
and length of stay. Another aspect to examine is whether a small number of patients are
admitted to the hospital frequently and if they make up the majority of admissions. Intervention
and education could play a major role in reducing those frequencies of hospital visits.
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Conclusion
Current studies on how length of stay impacts the care of patients with sickle cell disease,
asthma, and those with both sickle cell and asthma are limited. The goal of this study along with
others should improve awareness of the impact of these diseases on the pediatric population and
to aid in determining which patient population is at highest risk for longer admission rates. The
length of hospitalization can be important in determining and managing healthcare resources
within the hospital. It could also potentially impact the health care costs and quality of care
delivered to the patient. According to this study, age and diagnosis are not significant factors in
length of hospital stay for the pediatric patient. An overwhelming majority of the patients in the
study were African American, which is representative of both asthma and sickle cell disease in
the overall population. This study also showed that the patients tended to be younger, have
asthma as a discharge diagnosis, and length of stay less than 3 days. It is hoped that further
research will be conducted in order to provide clinicians with the comprehensive knowledge
needed to provide pediatric patients suffering from asthma and sickle cell disease with care that
may have a greater impact on patient outcomes.
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